Catherine Bresson
Director, Operational Team, WIN Consortium
Executive committee
Vladimir Lazar
Chief Scientific and Operating Officer, WIN Consortium
Razelle Kurzrock
Chief Medical Officer; Chair, Clinical Trials Committee, WIN Consortium
Amir Onn
Chair/Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)
Jacques Raynaud
Advisor to Operational Team, WIN Consortium; Member of Board and Past President, Fondation ARC for cancer research (France)
Richard L. Schilsky
Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)
Josep Tabernero
Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Operational team
Catherine Bresson
Director, Operational Team, WIN Consortium
Vladimir Lazar
Chief Scientific and Operating Officer, WIN Consortium
Layla El-Gharras
Assistant, Operational Team, WIN Consortium
Shai Magidi
IT Data Manager, WIN Consortium
Jacques Raynaud
Advisor to Operational Team, WIN Consortium; Member of Board and Past President, Fondation ARC for cancer research (France)
Eitan Rubin
Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head Bioinformatics, WIN Consortium
Hila Ventura
Data Manager, WIN Consortium
Fanny Wunder
Project Manager, WIN Consortium
Scientific Advisory Board
Andrea Califano
Vice Chairman of Scientific Advisory Board (SAB), WIN Consortium; Chair of Department of Systems Biology, Columbia University (USA)
Phillip G. Febbo
Chief Medical Officer and Senior Vice President, Clinical Genomics, Illumina (USA)
Robert L. Grossman
Professor, Medicine-Computational Biomedicine and Biomedical Data Science, University of Chicago (USA)
Stanley R. Hamilton
Chair and Professor, Department of Pathology, City of Hope Comprehensive Cancer Center (USA)
Leroy Hood
Chief Strategy Officer, Co-founder and Professor, Institute for Systems Biology (USA)
Pasi A. Jänne
Director, Lowe Center for Thoracic Oncology and Scientific Director, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (USA)
Yves A. Luisser
Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)
John Quackenbush
Professor, Computational Biology and Bioinformatics and Chair, Dept of Biostatistics, Harvard T.H Chan School of Public Health and Professor at Dana-Farber Cancer Institute (USA)
Gideon Rechavi
Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)
Gary L. Rosner
Director of the Quantitative Sciences Program and Biostatistics/Bioinformatics Division, Department of Oncology, John Hopkins Medicine (USA)
Lillian Siu
Senior Scientist, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada)
Alan Spatz
Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)
Josep Tabernero
Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Yosef Yarden
Professor, Weizmann Institute of Science (Israel)
Directorate
Gerald Batist
Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)
Cristiano de Pádua Souza
Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Pierre Fumoleau
General Manager, Institut Curie Hospital Group, Paris (France)
Nicolas Girard
Head of Department, Medical Oncology, Institut Curie (France)
Razelle Kurzrock
Chief Medical Officer; Chair, Clinical Trials Committee, WIN Consortium
Ulrik Lassen
Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)
Jean-François Martini
Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)
Ni Ming
Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)
Amir Onn
Chair/Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)
Prithwish Pal
Associate Director, Medical Affairs - Oncology, Illumina (USA)
Alejandro Piris
Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Angel Porgador
Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)
C.S. Pramesh
Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)
Jacques Raynaud
Advisor to Operational Team, WIN Consortium; Member of Board and Past President, Fondation ARC for cancer research (France)
Eitan Rubin
Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head Bioinformatics, WIN Consortium
Richard L. Schilsky
Chairman, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)
Marina Sekacheva
Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Benjamin M. Solomon
Asst Professor of Medicine, Avera Cancer Institute (USA)
Alan Spatz
Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)
Josep Tabernero
Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Casey Williams
Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)
General Assembly
Hikmat Abdel-Razeq
Chief Medical Officer, Chief Medical officer and Deputy Director General King Hussein Cancer Center (Jordan)
Amal Al Omari
Chief Scientific Officer, King Hussein Cancer Center (Jordan)
Fabrice André
Head of Research and Professor in Department of Medical Oncology, Gustave Roussy (France)
Gerald Batist
Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)
Guy Berchem
Head of Medical Oncology department, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)
Raanan Berger
Director, Institute of Oncology, Sheba Medical Center (Israel)
Jean-Yves Blay
Professor of Medicine, Université Claude Bernard; Scientific Director, Canceropole Lyon Rhône Alpes, Centre Léon Bérard (France)
Rares Buiga
Head of Pathology, The Oncology Institute Ion Chiricuta (IOCN) (Romania)
Anca Dana Buzoianu
Rector, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)
David Cantú de León
Deputy Director of Clinical Research, Instituto Nacional de Cancerologia (INCan)(Mexico)
Andrés Cervantes
Scientific Director, INCLIVA (Spain)
Zhen Chen
Vice President, Fudan University Shanghai Cancer Center (China)
Francesco De Lorenzo
Past President, Chair of the Scientific Committee, European Cancer Patient Coalition - ECPC (Belgium)
Cristiano de Pádua Souza
Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Michel Ducreux
Head of Digestive Oncology department, Gustave Roussy (France)
François Dupré
Director General, Fondation ARC (France)
Susan Galbraith
Senior Vice-President IMED Oncology, AstraZeneca, Gaithersburg MD (USA)
Manon Gantenbein
Head of Unit CIEC & CPMO, Clinical and Epidemiological Investigation Center, Luxembourg Institute of Health (Luxembourg)
Jean Claude Gérard
Senior Vice President European Operations, HTG Molecular (France)
Caroline Germa
Vice President, Head of the Clinical Group, AstraZeneca, Maryland (USA)
Nicolas Girard
Head of Department, Medical Oncology, Institut Curie (France)
Angel I. Guerrero-Zotano
Medical Oncologist, Instituto Valenciano de Oncología (IVO)(Spain)
Sadakatsu Ikeda
Associate Professor, Deputy Director, Tokyo Medical and Dental University Cancer Center (Japan)
Razelle Kurzrock
Chief Medical Officer; Chair, Clinical Trials Committee, WIN Consortium
Ulrik Lassen
Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)
Scott M. Lippman
Director, University of California San Diego Moores Cancer Center (USA)
José Antonio López-Guerrero
Head of Laboratory, Molecular Biologist and Geneticist, Instituto Valenciano de Oncología (IVO)(Spain)
Juan Martín Liberal
Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO), Barcelona (Spain)
Jean-François Martini
Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)
Ni Ming
Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)
Satoshi Miyake
Director, Tokyo Medical and Dental University Cancer Center (Japan)
Ioana Berindan-Neagoe
Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)
Hovav Nechushtan
Associate Professor, Oncology Department, Hadassah Hebrew University Medical School (Israel)
Finn Cilius Nielsen
Professor and Head of Centre for Genomic Medicine, Rigshospitalet (Denmark)
Amir Onn
Chair/Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)
Prithwish Pal
Associate Director, Medical Affairs - Oncology, Illumina (USA)
Thierry Philip
Chairman of the Board of directors, Institut Curie (France)
Alejandro Piris
Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Aron Popovtzer
Chairman, Hadassah Medical Center (Israel)
Angel Porgador
Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)
C.S. Pramesh
Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)
Eric Raymond
Head of Medical Oncology, Groupe Hospitalier Paris Saint-Joseph (France)
Jacques Raynaud
Advisor to Operational Team, WIN Consortium; Member of Board and Past President, Fondation ARC for cancer research (France)
Rui Manuel Reis
Executive and Scientific Director, Research and Education Institute, Coordinator, Molecular Oncology Research Center, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Eitan Rubin
Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head Bioinformatics, WIN Consortium
Joy Brewster Rusthoven
Executive Director, SURVIVEiT (USA)
Pierre Saintigny
Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)
Ramón Salazar
Head of Medical Oncology Department, Catalan Institute of Oncology (ICO), Barcelona, Spain
Marina Sekacheva
Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Manju Sengar
Medical Oncologist and Officer in charge, Clinical Research Secretariat, ACTREC - Tata Memorial Center (India)
Benjamin M. Solomon
Asst Professor of Medicine, Avera Cancer Institute (USA)
Alan Spatz
Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)
Andrey A. Svistunov
First Vice Rector for Innovation and International Affairs, I.M Sechenov First Moscow State Medical University (Russia)
Josep Tabernero
Vice Chairman, WIN Consortium; Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Raaj Trivedi
Global Market Development, Illumina (USA)
Casey Williams
Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)